Not known Factual Statements About evobrutinib
carbamazepine will minimize the extent or influence of pirfenidone by influencing hepatic enzyme CYP1A2 metabolism. Contraindicated. Use of powerful CYP1A2 inducers needs to be discontinued prior to initiating pirfenidone and avoided throughout therapy8 An interplay in between host and environmental components contributes to repetitive microinjurie